Compensatory responses to nigrostriatal bundle injury. Studies with 6-hydroxydopamine in an animal model of parkinsonism

Molecular and Chemical Neuropathology
M J ZigmondE M Stricker

Abstract

Intracerebral injections of the neurotoxin 6-hydroxydopamine (6-HDA) can produce selective, near-total destruction of the dopamine (DA)-containing neurons of the nigrostriatal bundle. The dysfunctions in animals with these lesions show many parallels with those present in Parkinsonian patients. Among these are the extensive loss of DA neurons in the basal ganglia, neurological impairments including akinesia, paradoxical kinesia in response to activating conditions, and improved sensory-motor function after the administration of DOPA. Moreover, as with patients with preclinical Parkinsonism, 6-HDA-treated rats with less extensive lesions show few or no behavioral dysfunctions, but are unusually sensitive to the akinesia-inducing effects of stress and dopaminergic antagonists. In this review, we summarize the behavioral effects of 6-HDA-induced depletion of striatal DA in the rat and then focus on the compensatory changes that may underlie the preclinical stage of the disorder. These compensations appear to include an increase in the number of active DA neurons, an increase in the release of DA per impulse from residual terminals, and a decrease in the amount of DA inactivated by high affinity uptake. Collectively, these alterati...Continue Reading

References

Jun 1, 1976·Journal of Comparative and Physiological Psychology·J F MarshallE M Stricker
Mar 1, 1976·Physiology & Behavior·T Ljungberg, U Ungerstedt
Jan 1, 1975·Biochemical Pharmacology·C Sachs, G Jonsson
Nov 1, 1985·Annals of Neurology·A M SnyderM J Zigmond
Jan 1, 1971·Acta Physiologica Scandinavica. Supplementum·U Ungerstedt
Jan 1, 1968·Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie·H Thoenen, J P Tranzer
May 1, 1973·Pharmacology, Biochemistry, and Behavior·G R BreeseL D Grant
Jun 1, 1974·Journal of Comparative and Physiological Psychology·E M Stricker, M J Zigmond
May 1, 1972·European Journal of Pharmacology·B R JacksJ P Cordeau
Oct 15, 1972·Experientia·R E Heikkila, G Cohen
Feb 1, 1970·Journal of Neurochemistry·N J Uretsky, L L Iversen
May 1, 1971·British Journal of Pharmacology·G R Breese, T D Traylor
Dec 1, 1968·European Journal of Pharmacology·U Ungerstedt
Jan 1, 1984·Journal of Neural Transmission·T A Reader, P Gauthier
Jul 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·E MelamedR J Wurtman
Jan 1, 1983·Journal of Neural Transmission·W BirkmayerP Riederer

❮ Previous
Next ❯

Citations

Aug 6, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·E GrünblattM B Youdim
Jan 1, 1993·Movement Disorders : Official Journal of the Movement Disorder Society·M B YoudimP Riederer
Jan 1, 1993·Journal of Neural Transmission. General Section·A A Grace
Jan 1, 1991·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·N C Harris, S A Greenfield
Nov 28, 2008·European Journal of Nuclear Medicine and Molecular Imaging·S A EshuisK L Leenders
Dec 19, 1996·European Journal of Pharmacology·D MartinD Russell
Oct 17, 1998·Progress in Neurobiology·W Hauber
Dec 25, 2002·Free Radical Biology & Medicine·Jos L VeneroAlberto Machado
Jan 5, 2012·The Journal of Clinical Investigation·Hsien-yang LeeLouis J Ptácek
Apr 1, 2014·Experimental Neurology·Timothy J Collier
Jan 1, 1991·Neurochemical Research·F F OldfieldA Y Sun
Jan 9, 2003·Archives of Physiology and Biochemistry·K G UsunoffE Marani
Mar 26, 1998·Experimental Neurology·H M SchipperE G Stopa
Sep 6, 2012·The International Journal of Neuropsychopharmacology·John D ElsworthRobert H Roth
Apr 27, 2012·Journal of Biomedicine & Biotechnology·Javier BlesaSerge Przedborski
Feb 28, 2002·The European Journal of Neuroscience·J F Cahill, M G Baxter
Dec 6, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·T Celeste NapierAntonio P Strafella
Jan 15, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Cameron H GoodCarl R Lupica
Mar 11, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Maja KojovicKailash P Bhatia
Aug 23, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Christopher J Madden, Alan F Sved

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.